High-throughput oncogene mutation profiling in human cancerRoman K. Thomas, Meenhard Herlyn, Alissa C. Baker et al.|Nature Genetics|2007Cited by 996
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, C. Allison Stewart et al.|Cancer Cell|2021Cited by 930
Activating Mutations of the Noonan Syndrome-Associated <b> <i>SHP2/PTPN11</i> </b> Gene in Human Solid Tumors and Adult Acute Myelogenous LeukemiaMohamed Bentires‐Alj, Benjamin G. Neel, Balázs Halmos et al.|Cancer Research|2004Cited by 512
ZEB1 drives epithelial-to-mesenchymal transition in lung cancerJill E. Larsen, John D. Minna|Journal of Clinical Investigation|2016Cited by 344
A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple MalignanciesDavid S. Shames, John D. Minna|PLoS Medicine|2006Cited by 274